June 13, 2011
Bernstein Liebhard LLP is investigating whether the Board of Directors of Gerber Scientific, Inc. (“Gerber Scientific” or the “Company”) (NYSE: GRB) breached its fiduciary duty to its shareholders in agreeing to sell Gerber Scientific to funds affiliated with Vector Capital Corporation.
Under the terms of the agreement, Gerber Scientific shareholders will receive $11.00 in cash for each share they own. The investigation is focused on the potential unfairness of the price to Gerber Scientific shareholders and the process by which the Gerber Scientific Board of Directors considered and approved the transaction.
If you are interested in discussing your rights as a Gerber Scientific shareholder and/or have information relating to the matter, please contact U. Seth Ottensoser at (877) 779-1414 or Ottensoser@bernlieb.com.
Bernstein Liebhard has pursued hundreds of securities, consumer and shareholder rights cases and recovered almost $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last eight years.